Genmab A GMAB
NASDAQ GMAB
$40.00 +0.43 (+1.09%)
At close: Oct 22, 2026 · 4:00 PM EDT

Genmab A (GMAB) Debt Ratio (2025 - 2026)

Updated

Genmab A's (GMAB) Debt Ratio came in at 0.41 for the quarter ended Jun 30, 2026, up 2.9% from the prior quarter.

Analysis

Genmab A (GMAB) Debt Ratio (2025 - 2026) Analysis & Trends

For the year ended Dec 31, 2025, Genmab A's Debt Ratio stood at 0.43.

  • In prior years, Genmab A's Debt Ratio was 0.01 in the year ended Dec 31, 2021 (+12.5%).
  • Quarterly Debt Ratio has run from a low of 0.01 in the quarter ended Dec 31, 2021 to a high of 0.43 in the quarter ended Dec 31, 2025 over five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 0.39
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn 0.23
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn 0.52
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn 0.42
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn 0.08
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn 0.28
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn 0.60
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 0.53
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn 0.31
10 Genmab A 2.58 Bn -2.80 Bn 1.07 Bn 0.41
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 0.41
Mar 31, 2026 0.40
Dec 31, 2025 0.41
API Access

Genmab A Debt Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=debt-ratio&ticker=GMAB&period=max&api_key=YOUR_API_KEY